Alkem Laboratories Limited — Board Meeting, 28-05-2026: Outcome of Board Meeting
28-05-2026 | 01:25 pm
28-05-2026 | 01:25 pm
Alkem Laboratories' board approved strong FY26 consolidated results: Revenue at ₹14,712.27 Cr & Net Profit at ₹2,301.8 Cr. They also declared a final dividend of ₹10/share (total ₹53/share for FY26) and re-approved Mrs. Madhurima Singh as Executive Director.
No comments yet. Be the first to comment!
